News & Events
Extrave BioScience, founded by Matthew Hudson, an assistant professor in the Department of Kinesiology and Applied Physiology, has developed technology with the potential to reverse the pathology in muscular dystrophy. This company, which grew out of University of Delaware research and is licensing UD-developed technology, was named as one of two winners of the 2019 University of Delaware FastPass competition. This program, run by the Delaware Innovation Space, will award both startups a support package valued at $50,000. Read more here.
Dr. Hudson is a finalist in the Science Center’s QED Proof-of-Concept Program for Academic Researchers for drug delivery using cell fragments. Read more here.
Collaborative paper published on hyperthermia and autophagy with Dr. Josh Selsby’s lab.
Congratulations to Eric Munoz on receiving the Office of Graduate and Professional Education’s Graduate Scholar Award!
Collaborative paper published on DHA prevention of muscle atrophy with Dr. Russ Price’s lab.
Collaborative paper published on oxidative stress and autophagy with Dr. Ashley Smuder’s lab
Carina Pautz and Dr. Wilson present at the MARC ACSM conference. Here Carina Pautz discusses her extracellular vesicle research.
Dr. Hudson briefly discussing taking antioxidant supplements while exercising with Men’s Health Magazine. Read the full article here.
Dr. Hudson briefly discusses epsom salt baths with Tonic (Vice)
Carolina Caban receives the Charles Hodge IV Prize in Biology.
Dr. Hudson, Carina Pautz and Carolina Caban present research at the Experimental Biology meeting in Chicago.
Katie Pinson discusses research and working in the Hudson Lab. Read the full article here.
At the MARC ACSM conference Katie Pinson wins the undergraduate student investigator award, Eric Munoz wins the masters of science student investigator award, and Brittany Wilson and Carina Pautz were both selected to compete in the doctoral student awards symposium.
Carolina Caban presents her work in the lab on elucidating a blood biomarker of concussion/head impact at the MARC ACSM meeting.
Are mild head impacts more dangerous than we think?